Contamination from ethylene glycol and diethylene glycol in liquid formulation poses a high risk to patient safety. Throughout recent years there have been multiple fatalities reported due to the presence of these contaminants in drug products. This webinar covers the testing of high-risk drug components for ethylene glycol and diethylene glycol.
This webinar is ideal for
- Pharma manufacturers
- Compounders
- CDMOs
- CROs
